Oxford Global’s Biologics Series features 3 outstanding programmes: our long-running 12th Annual Proteins and Antibodies Congress, and co-located with our highly anticipated 6th Annual Peptides Congress and 6th Annual Biosimilars & Biobetters Congress

Over 500 proteins, antibodies, peptides and biosimilars & biobetters attendees representing global pharmaceutical organizations, leading biotech companies and internationally renowned academic institutions will be joining this international series of events

12th Annual Proteins and Antibodies Congress: Gain valuable insights into the most innovative protein and antibody engineering & development strategies, biotherapeutic manufacturing and analytic considerations and the alternative scaffolds impacting this marketplace. Over the 2 days, the programme explores critical advances in Protein and Antibody Engineering; examines the potentials in Bioconjugates, Cloning, Expressions, Purification and Cell Engineering as well as the key successes in Biotherapeutics manufacturing and analytical development. Do not miss out hearing world class presentations on recent Biotherapeutic development including CAR T therapy and Immuno-Oncology. Additionally, the event will feature two workshops, concentrating on Predicting Protein Stability and Analytics & CRISPS CAS 9 in Proteins and Antibodies.

6th Annual Peptides Congress: With key developments in synthesis and discovery, a high interest in peptide conjugates and the exploration of drug delivery methods, we’re seeing more and more peptides heading towards clinical trials. Fuelling this growth is the application of peptides to key medical threats such as antimicrobial resistance, cancer and metabolic disorders as well as a shifting industry focus on biologics. This congress will take you through three key stages of peptide development from peptide research to therapeutics and manufacturing letting you hear real results from high profile industry players through a series of case studies and best practice style presentations.

6th Annual Biosimilars & Biobetters Congress: Explore the latest updates in the biosimilars field: regulatory approval and the introduction of biosimilar medicines in clinical practice, its challenges, opportunities and barriers. Prominent leaders will discuss the key challenges of interchangeability and substitution to enable effective market uptake. Additionally, the event will feature case studies of developing Biosimilars and Biobetters taken into account of CMC, Manufacturing and Analytics considerations. Do not miss out on meeting with regulators, healthcare leaders as well as senior attendees from pharmaceutical companies.